Prediction Case File
YouTubeTracking Live

Amazon Is Defying The Market—$300 Next? 📦🚀

1 extracted signal · 0 resolved · 1 still active

Stocks with Josh profile imageStocks with JoshIndependent analyst profile
Source published
06 Nov 2026, 20:34 UTC
Recorded by Tahlil Plus
06 Nov 2026, 23:45 UTC
Video preview for Amazon Is Defying The Market—$300 Next? 📦🚀
Source overview

AI-generated source summary

The speaker highlights Amazon (AMZN) as an outperforming asset and a top pick for 2026. Despite broader market weakness, AMZN has shown relative strength, bouncing from a buy price of $227 up to $273. The technical outlook remains bullish, with a target of $300 expected within the next six months barring major macroeconomic events.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Stocks with Josh

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
12
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail